| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |